COUMARINS TO INHIBIT REVERSE TRANSCRIPTASE IN HUMANS

The following compounds: 6-bromo-3-[(m-chlorophenyl)carbamoyl]-coumarin, 6-bromo-3-[( alpha , alpha , alpha -trifluoro-m-toluyl)carbamoyl]coumarin, 6-bromo-3-[(2,5-dichlorophenyl)carbamoyl]coumarin, [[bis(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-methyl]cyclopentadienyl]cy clopentadienyl-iron, 3-cinnamo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: REUSSER, FRITZ, TARPLEY, WILLIAM, G, ALTHAUS, IRENE, W, DOLAK, LESTER
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator REUSSER, FRITZ
TARPLEY, WILLIAM, G
ALTHAUS, IRENE, W
DOLAK, LESTER
description The following compounds: 6-bromo-3-[(m-chlorophenyl)carbamoyl]-coumarin, 6-bromo-3-[( alpha , alpha , alpha -trifluoro-m-toluyl)carbamoyl]coumarin, 6-bromo-3-[(2,5-dichlorophenyl)carbamoyl]coumarin, [[bis(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-methyl]cyclopentadienyl]cy clopentadienyl-iron, 3-cinnamoyl-4-hydroxy-coumarin, hexachlorocoumarin, 7-acetoxy-coumarin or [1-(2-oxo-2H-1-benzopyran-3-yl)ethylidene]-hydrazinecarboxylic acid phenylmethyl ester or pharmaceutically acceptable salts thereof can be used to treat humans infected with one or more than one strain of a human immunodeficiency virus.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO8907939A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO8907939A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO8907939A33</originalsourceid><addsrcrecordid>eNrjZDBx9g_1dQzy9AtWCPFX8PTz8HTyDFEIcg1zDQp2VQgJcvQLdg7yDAhxBPI8_RQ8gIr9gnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXy4v4WlgbmlsaWjsTERSgCd0SeA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COUMARINS TO INHIBIT REVERSE TRANSCRIPTASE IN HUMANS</title><source>esp@cenet</source><creator>REUSSER, FRITZ ; TARPLEY, WILLIAM, G ; ALTHAUS, IRENE, W ; DOLAK, LESTER</creator><creatorcontrib>REUSSER, FRITZ ; TARPLEY, WILLIAM, G ; ALTHAUS, IRENE, W ; DOLAK, LESTER</creatorcontrib><description>The following compounds: 6-bromo-3-[(m-chlorophenyl)carbamoyl]-coumarin, 6-bromo-3-[( alpha , alpha , alpha -trifluoro-m-toluyl)carbamoyl]coumarin, 6-bromo-3-[(2,5-dichlorophenyl)carbamoyl]coumarin, [[bis(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-methyl]cyclopentadienyl]cy clopentadienyl-iron, 3-cinnamoyl-4-hydroxy-coumarin, hexachlorocoumarin, 7-acetoxy-coumarin or [1-(2-oxo-2H-1-benzopyran-3-yl)ethylidene]-hydrazinecarboxylic acid phenylmethyl ester or pharmaceutically acceptable salts thereof can be used to treat humans infected with one or more than one strain of a human immunodeficiency virus.</description><edition>4</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1989</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19891019&amp;DB=EPODOC&amp;CC=WO&amp;NR=8907939A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19891019&amp;DB=EPODOC&amp;CC=WO&amp;NR=8907939A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>REUSSER, FRITZ</creatorcontrib><creatorcontrib>TARPLEY, WILLIAM, G</creatorcontrib><creatorcontrib>ALTHAUS, IRENE, W</creatorcontrib><creatorcontrib>DOLAK, LESTER</creatorcontrib><title>COUMARINS TO INHIBIT REVERSE TRANSCRIPTASE IN HUMANS</title><description>The following compounds: 6-bromo-3-[(m-chlorophenyl)carbamoyl]-coumarin, 6-bromo-3-[( alpha , alpha , alpha -trifluoro-m-toluyl)carbamoyl]coumarin, 6-bromo-3-[(2,5-dichlorophenyl)carbamoyl]coumarin, [[bis(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-methyl]cyclopentadienyl]cy clopentadienyl-iron, 3-cinnamoyl-4-hydroxy-coumarin, hexachlorocoumarin, 7-acetoxy-coumarin or [1-(2-oxo-2H-1-benzopyran-3-yl)ethylidene]-hydrazinecarboxylic acid phenylmethyl ester or pharmaceutically acceptable salts thereof can be used to treat humans infected with one or more than one strain of a human immunodeficiency virus.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1989</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBx9g_1dQzy9AtWCPFX8PTz8HTyDFEIcg1zDQp2VQgJcvQLdg7yDAhxBPI8_RQ8gIr9gnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXy4v4WlgbmlsaWjsTERSgCd0SeA</recordid><startdate>19891019</startdate><enddate>19891019</enddate><creator>REUSSER, FRITZ</creator><creator>TARPLEY, WILLIAM, G</creator><creator>ALTHAUS, IRENE, W</creator><creator>DOLAK, LESTER</creator><scope>EVB</scope></search><sort><creationdate>19891019</creationdate><title>COUMARINS TO INHIBIT REVERSE TRANSCRIPTASE IN HUMANS</title><author>REUSSER, FRITZ ; TARPLEY, WILLIAM, G ; ALTHAUS, IRENE, W ; DOLAK, LESTER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO8907939A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1989</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>REUSSER, FRITZ</creatorcontrib><creatorcontrib>TARPLEY, WILLIAM, G</creatorcontrib><creatorcontrib>ALTHAUS, IRENE, W</creatorcontrib><creatorcontrib>DOLAK, LESTER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>REUSSER, FRITZ</au><au>TARPLEY, WILLIAM, G</au><au>ALTHAUS, IRENE, W</au><au>DOLAK, LESTER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COUMARINS TO INHIBIT REVERSE TRANSCRIPTASE IN HUMANS</title><date>1989-10-19</date><risdate>1989</risdate><abstract>The following compounds: 6-bromo-3-[(m-chlorophenyl)carbamoyl]-coumarin, 6-bromo-3-[( alpha , alpha , alpha -trifluoro-m-toluyl)carbamoyl]coumarin, 6-bromo-3-[(2,5-dichlorophenyl)carbamoyl]coumarin, [[bis(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-methyl]cyclopentadienyl]cy clopentadienyl-iron, 3-cinnamoyl-4-hydroxy-coumarin, hexachlorocoumarin, 7-acetoxy-coumarin or [1-(2-oxo-2H-1-benzopyran-3-yl)ethylidene]-hydrazinecarboxylic acid phenylmethyl ester or pharmaceutically acceptable salts thereof can be used to treat humans infected with one or more than one strain of a human immunodeficiency virus.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_WO8907939A3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title COUMARINS TO INHIBIT REVERSE TRANSCRIPTASE IN HUMANS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T00%3A58%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=REUSSER,%20FRITZ&rft.date=1989-10-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO8907939A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true